Found: 2

Select item for more details and to access through your institution.

  • Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis.

    Published in:
    Neurological Research & Practice, 2022, v. 4, n. 1, p. 1, doi. 10.1186/s42466-022-00219-3
    By:
    • Regner-Nelke, Liesa;
    • Pawlitzki, Marc;
    • Willison, Alice;
    • Rolfes, Leoni;
    • Oezalp, Sinem-Hilal;
    • Nelke, Christopher;
    • Kölsche, Tristan;
    • Korsen, Melanie;
    • Grothe, Matthias;
    • Groppa, Sergiu;
    • Luessi, Felix;
    • Engel, Sinah;
    • Nelles, Gereon;
    • Bonmann, Eckhard;
    • Roick, Holger;
    • Friedrich, Anke;
    • Knorn, Philipp;
    • Landefeld, Harald;
    • Biro, Zoltan;
    • Ernst, Michael
    Publication type:
    Article

  • Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis.

    Published in:
    Neurological Research & Practice, 2022, v. 4, n. 1, p. 1, doi. 10.1186/s42466-022-00219-3
    By:
    • Regner-Nelke, Liesa;
    • Pawlitzki, Marc;
    • Willison, Alice;
    • Rolfes, Leoni;
    • Oezalp, Sinem-Hilal;
    • Nelke, Christopher;
    • Kölsche, Tristan;
    • Korsen, Melanie;
    • Grothe, Matthias;
    • Groppa, Sergiu;
    • Luessi, Felix;
    • Engel, Sinah;
    • Nelles, Gereon;
    • Bonmann, Eckhard;
    • Roick, Holger;
    • Friedrich, Anke;
    • Knorn, Philipp;
    • Landefeld, Harald;
    • Biro, Zoltan;
    • Ernst, Michael
    Publication type:
    Article